ArticleEthics & human research2019

Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research.

Bryan Anthony Sisk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.